ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1689

Using Electronic Health Record Algorithms to Accurately Identify Patients with Systemic Sclerosis

Lia Jamian, Leslie Crofford and April Barnado, Medicine, Vanderbilt University Medical Center, Nashville, TN

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Electronic Health Record, phenotypes and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is a rare, chronic, autoimmune disease with high morbidity and mortality. The electronic health record (EHR) represents a powerful tool to study rare disorders such as SSc. Currently, there are no validated algorithms to identify SSc patients in the EHR. We sought to develop algorithms that incorporated not only billing codes but also labs and keywords to identify SSc patients accurately.           Methods: We analyzed data from a de-identified version of Vanderbilt’s EHR called the Synthetic Derivative (SD) that contains over 2.8 million subjects with longitudinal clinical data.  Within the SD, we identified 1899 potential SSc patients with at least one count of the SSc ICD-9 (710.1) code. Of these potential subjects, we randomly selected 200 as a training set for chart review to identify true case status. A subject was defined as a case if diagnosed with SSc by a Vanderbilt or external rheumatologist, dermatologist, or pulmonologist. Potential subjects were then classified as either 1) cases, 2) not cases with alternative diagnoses noted, 3) unconfirmed if there was uncertainty in the diagnosis, or 4) missing if clinical documentation was missing. A priori, we selected the following potential algorithm components based on clinical knowledge and available data: SSc ICD-9 code, positive anti-nuclear antibody (ANA) (titer ≥ 1:80), and a keyword of Raynaud’s phenomenon (RP) in the clinic notes. Positive predictive values (PPVs) and sensitivity were calculated for combinations of the above algorithm components.           Results: Of the 200 subjects in the training set, 81 were true cases on chart review, 65 not cases, 17 unconfirmed, and 37 with missing clinical documentation. The PPV for using 1 count of the SSc ICD-9 code was 50%, 68% for ≥ 2 counts, 82% for ≥ 3 counts, and 90% for ≥ 4 counts. PPVs increased when a positive ANA or RP keyword was added to the ICD-9 code. The algorithms with the highest PPVs of 96% were 1) ≥ 4 counts of the SSc ICD-9 code and RP keyword, 2) ≥ 3 counts of the SSc ICD-9 code and ANA positive and RP keyword, and 3) ≥ 4 counts of the SSc ICD-9 code and ANA positive and RP keyword (Table 1).  The algorithm with the highest combined PPV of 81% and sensitivity of 95% was ≥ 1 count of the SSc ICD-9 code and RP keyword.     Conclusion: We have developed novel algorithms to identify SSc subjects in the EHR using not only billing codes but also labs and keywords with a PPV of 96%.  These algorithms will allow researchers to identify and study patients with SSc more efficiently and accurately in the EHR.  

Table 1.

Algorithm*

Positive Predictive Value

Sensitivity

Counts of the ICD-9 code (710.1)*

 

 

≥ 1

50%

N/A

≥ 2

68%

85%

≥ 3

82%

77%

≥ 4

90%

67%

 

 

 

ANA positive£ AND ≥ 1 count of 710.1

45 %

81%

ANA positive AND ≥ 2 counts

70%

81%

ANA positive AND ≥ 3 counts

88%

67%

ANA positive AND ≥ 4 counts

93%

58%

 

 

 

Raynaud’s phenomenon (RP) keyword AND ≥ 1 count of 710.1

81%

95%

RP keyword AND ≥ 2 counts

91%

80%

RP keyword AND ≥ 3 counts

94%

71%

RP keyword AND ≥ 4 counts

96%

67%

 

 

 

ANA positive AND RP keyword AND ≥ 1 count of 710.1

74%

78%

ANA positive AND RP AND ≥ 2 counts

94%

76%

ANA positive AND RP AND ≥ 3 counts

96%

64%

ANA positive AND RP AND ≥ 4 counts

96%

57%

 

 

 

ANA positive OR RP keyword AND ≥ 1 count of 710.1

49%

98%

ANA positive OR RP AND ≥ 2 counts

72%

90%

ANA positive OR RP AND ≥ 3 counts

89%

76%

ANA positive OR RP AND ≥ 4 counts

93%

67%

*All algorithms included at least one or more counts of the Systemic Sclerosis ICD-9 (710.1). £ANA positive defined as titer ≥ 1:80.

Disclosure: L. Jamian, None; L. Crofford, None; A. Barnado, None.

To cite this abstract in AMA style:

Jamian L, Crofford L, Barnado A. Using Electronic Health Record Algorithms to Accurately Identify Patients with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/using-electronic-health-record-algorithms-to-accurately-identify-patients-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-electronic-health-record-algorithms-to-accurately-identify-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology